Your session is about to expire
← Back to Search
Behavioral Intervention
Diabetes Medication Choice decision aid for Type 2 Diabetes
N/A
Waitlist Available
Led By Victor M. Montori, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
The purpose of this study is to examine how different ways of sharing information about diabetes medication treatment options with patients can affect their choices and health.
Eligible Conditions
- Type 2 Diabetes
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
Patients and clinicians in this arm will discuss anti-hyperglycemic agents in their usual manner.
Group II: Diabetes Medication Choice decision aidExperimental Treatment1 Intervention
Patients in this arm will discuss diabetes medication for glucose control with the help of a decision aid that covers five commonly prescribed anti-hyperglycemic medications.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Diabetes Medication Choice decision aid
2006
N/A
~290
Usual Care
1990
Completed Phase 4
~7700
Find a Location
Who is running the clinical trial?
American Diabetes AssociationOTHER
141 Previous Clinical Trials
99,543 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,298 Previous Clinical Trials
3,958,360 Total Patients Enrolled
Victor M. Montori, M.D.Principal InvestigatorMayo Clinic
3 Previous Clinical Trials
277 Total Patients Enrolled
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger